Skip to main content
. Author manuscript; available in PMC: 2023 Feb 3.
Published in final edited form as: J Med Econ. 2021 Jan-Dec;24(1):1060–1069. doi: 10.1080/13696998.2021.1965732

Figure 3.

Figure 3.

Cost-effectiveness acceptability curve of the probability that a comparator is cost-effective at a given cost-effectiveness threshold, based on results of a probabilistic sensitivity analysis of 10,000 Monte Carlo simulations.

Definitions: QALY, quality-adjusted life year.